It may induce Nrf2 dissociation, increase the expression of phase II enzymes such as HO-1, GSTs and NQO1 by combining with nucleophiles (such as Keap1) in cells and can be used to treat pulmonary fibrosis (Divya et al., 2016). The gene discussed is HPGDS; the disease is pulmonary fibrosis.